All news – radiomics.bio

What’s going on at radiomics.bio?

What’s going on at radiomics.bio?

All news

Posted October 16th, 2025

radiomics.bio and AstraZeneca join forces to explore the potential for an AI model to predict interstitial lung disease related to cancer treatment

Posted January 10th, 2025

radiomics.bio Announces New Chairman

Posted January 10th, 2025

Paul Mauhin appointed Chief Financial Officer of radiomics.bio, succeeding Mathieu Delvaux

Posted February 29th, 2024

From Images to Impact: Radiomics’ Solutions to Challenges in Immunotherapy

Posted September 5th, 2023

Pilot project at the Jewish General Hospital aims to accelerate access to new and highly effective treatments for cancer patients

Posted April 7th, 2023

Belgian biotech companies DeuterOncology and Radiomics combine their expertise to improve cancer therapy

Posted November 23rd, 2022

Radiomics’ Event Package For IO Xchange

Posted November 14th, 2022

Early Detection with Imaging

Posted October 14th, 2022

Radiomics’ Remarkable Relocation

Posted September 8th, 2022

Radiomics’ Events Package For ESMO

Posted July 15th, 2022

New Beginnings

Posted April 21st, 2022

The clinical needs and regulatory requirements of an imaging-based companion diagnostic

Posted April 15th, 2022

Radiomics’ Sustainability Policy

Posted March 24th, 2022

Radiomics’ Events Information Package For ASCO

Posted March 22nd, 2022

Technical considerations for an imaging-based companion diagnostic

Posted March 15th, 2022

Radiomics is officially ISO 13485 certified